These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34139772)

  • 1. Effect of DDAVP on Platelet Activation and Platelet-Derived Microparticle Generation.
    Persyn M; Athanase N; Trossaërt M; Sigaud M; Ternisien C; Béné MC; Fouassier M
    Hamostaseologie; 2022 Jun; 42(3):185-192. PubMed ID: 34139772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-DDAVP thrombocytopenia in type 2B von Willebrand disease is not associated with platelet consumption: failure to demonstrate glycocalicin increase or platelet activation.
    Casonato A; Steffan A; Pontara E; Zucchetto A; Rossi C; De Marco L; Girolami A
    Thromb Haemost; 1999 Feb; 81(2):224-8. PubMed ID: 10063996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of desmopressin on platelet function: a selective enhancement of procoagulant COAT platelets in patients with primary platelet function defects.
    Colucci G; Stutz M; Rochat S; Conte T; Pavicic M; Reusser M; Giabbani E; Huynh A; Thürlemann C; Keller P; Alberio L
    Blood; 2014 Mar; 123(12):1905-16. PubMed ID: 24443440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease.
    Holmberg L; Nilsson IM; Borge L; Gunnarsson M; Sjörin E
    N Engl J Med; 1983 Oct; 309(14):816-21. PubMed ID: 6412139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired release of tissue plasminogen activator (t-PA) following DDAVP infusion in von Willebrand's disease with low platelet von Willebrand factor content.
    Casonato A; Sartori MT; Pontara E; Zucchetto A; Dannhäuser D; Patrassi G; Girolami A
    Blood Coagul Fibrinolysis; 1992 Apr; 3(2):149-53. PubMed ID: 1606286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 1-desamino-8-D-arginine vasopressin (DDAVP) on human platelets.
    Yang X; Disa J; Rao AK
    Thromb Res; 1990 Sep; 59(5):809-18. PubMed ID: 2237837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-Deamino-8-D-arginine vasopressin (DDAVP) increases platelet membrane expression of glycoprotein Ib in patients with disorders of platelet function and after cardiopulmonary bypass.
    Sloand EM; Alyono D; Klein HG; Chang P; Yu M; Lightfoot FG; Kessler C
    Am J Hematol; 1994 Jul; 46(3):199-207. PubMed ID: 8192149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desmopressin (DDAVP) improves recruitment of activated platelets to collagen but simultaneously increases platelet endothelial interactions in vitro.
    Calmer S; Ferkau A; Larmann J; Johanning K; Czaja E; Hagl C; Echtermeyer F; Goudeva L; Heuft HG; Theilmeier G
    Platelets; 2014; 25(1):8-15. PubMed ID: 23534885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties of the factor VIII after DDAVP (1-deamino-8-D-arginine vasopressin) infusion in normal subjects.
    Takahashi H; Itoh M; Kobayashi I; Sakuragawa N; Shibata A
    Tohoku J Exp Med; 1980 Oct; 132(2):133-40. PubMed ID: 6777902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shortening of bleeding time by 1-deamino-8-D-arginine vasopressin in various bleeding disorders.
    Kobrinsky NL; Israels ED; Gerrard JM; Cheang MS; Watson CM; Bishop AJ; Schroeder ML
    Lancet; 1984 May; 1(8387):1145-8. PubMed ID: 6144876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-treatment of porcine pulmonary xenograft with desmopressin: a novel strategy to attenuate platelet activation and systemic intravascular coagulation in an ex-vivo model of swine-to-human pulmonary xenotransplantation.
    Kim YT; Lee HJ; Lee SW; Kim JY; Wi HC; Park SJ; Bae SJ; Kang HJ
    Xenotransplantation; 2008 Feb; 15(1):27-35. PubMed ID: 18333911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet--von Willebrand factor interactions in type IIB von Willebrand's disease.
    Holmberg L; Kristoffersson AC; Lamme S; Nilsson IM; Awidi A; Solum NO
    Scand J Haematol; 1985 Sep; 35(3):305-14. PubMed ID: 3877338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DDAVP: a useful alternative to blood components in moderate hemophilia A and von Willebrand disease.
    Warrier AI; Lusher JM
    J Pediatr; 1983 Feb; 102(2):228-33. PubMed ID: 6401806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of desamino-D-arginine vasopressin (DDAVP) and naloxone infusions on factor VIII and possible endothelial cell (EC) related activities.
    Moffat EH; Giddings JC; Bloom AL
    Br J Haematol; 1984 Aug; 57(4):651-62. PubMed ID: 6430337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand's disease.
    Mannucci PM; Canciani MT; Rota L; Donovan BS
    Br J Haematol; 1981 Feb; 47(2):283-93. PubMed ID: 6781527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DDAVP enhances the ability of blood monocytes to form rosettes with activated platelets by increasing the expression of P-selectin sialylated ligands on the monocyte surface.
    Pereira A; del Valle Onorato M; Sanz C
    Br J Haematol; 2003 Mar; 120(5):814-20. PubMed ID: 12614215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DDAVP-induced enhancement of platelet retention: its dependence on platelet-von Willebrand factor and the platelet receptor GP IIb/IIIa.
    Lethagen S; Nilsson IM
    Eur J Haematol; 1992 Jul; 49(1):7-13. PubMed ID: 1499698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of DDAVP infusion on thrombin generation in platelet-rich plasma of von Willebrand type 1 and in mild haemophilia A patients.
    Keularts IM; Hamulyak K; Hemker HC; Béguin S
    Thromb Haemost; 2000 Oct; 84(4):638-42. PubMed ID: 11057863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of effect of 1-desamino-8-D-arginine vasopressin on direct adhesion of platelets to collagen.
    Ghosh S; Rao AK
    Thromb Res; 1993 Jun; 70(5):417-22. PubMed ID: 7690994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor VII and fibrinolytic response to deamino-8-D-argenine vasopressin in normal subjects and dissociate response in some patients with haemophilia and von Willebrand's disease.
    Ludlam CA; Peake IR; Allen N; Davies BL; Furlong RA; Bloom AL
    Br J Haematol; 1980 Jul; 45(3):499-511. PubMed ID: 6775673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.